A K Ludwig1, M Glawatz, G Griesinger, K Diedrich, M Ludwig. 1. Department of Gynaecology and Obstetrics, University of Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany. a.k.ludwig@web.de
Abstract
BACKGROUND: Although transvaginal ultrasound-guided oocyte retrievals (OR) are performed routinely worldwide, there is very little systematic data about its complications. METHODS: We performed a prospective cohort study following the perioperative and post-operative complications of over 1058 ORs. Additionally, we assessed the pain experienced during the OR. RESULTS: A total of 1166 OR were performed during the study period, of which 1058 (90.7%) ORs were included prospectively. Incomplete data meant that the remaining 9.3% were excluded. No complications were caused by sedation or general anaesthesia. Vaginal bleeding was observed in 2.8% of procedures, without any cases of intra-abdominal bleeding. An injury of pelvic structures (a ureteral lesion) occurred in one case. No case of pelvic infection, but one case of unexplained fever, was observed. A severe ovarian hyperstimulation syndrome (OHSS) occurred in 2.7% of cases. Although most patients tolerated the OR well, 3% of patients experienced severe to very severe pain after the OR and 2% of patients were still suffering from severe pain 2 days after the procedure. The pain level increased with the number of oocytes retrieved. About 0.7% of patients required hospitalization for pain treatment. CONCLUSIONS: Patients can be reassured that overall OR is a safe procedure. However, patients have to be counselled about the minor risks of the OR. The literature on complications is reviewed in the article.
BACKGROUND: Although transvaginal ultrasound-guided oocyte retrievals (OR) are performed routinely worldwide, there is very little systematic data about its complications. METHODS: We performed a prospective cohort study following the perioperative and post-operative complications of over 1058 ORs. Additionally, we assessed the pain experienced during the OR. RESULTS: A total of 1166 OR were performed during the study period, of which 1058 (90.7%) ORs were included prospectively. Incomplete data meant that the remaining 9.3% were excluded. No complications were caused by sedation or general anaesthesia. Vaginal bleeding was observed in 2.8% of procedures, without any cases of intra-abdominal bleeding. An injury of pelvic structures (a ureteral lesion) occurred in one case. No case of pelvic infection, but one case of unexplained fever, was observed. A severe ovarian hyperstimulation syndrome (OHSS) occurred in 2.7% of cases. Although most patients tolerated the OR well, 3% of patients experienced severe to very severe pain after the OR and 2% of patients were still suffering from severe pain 2 days after the procedure. The pain level increased with the number of oocytes retrieved. About 0.7% of patients required hospitalization for pain treatment. CONCLUSIONS:Patients can be reassured that overall OR is a safe procedure. However, patients have to be counselled about the minor risks of the OR. The literature on complications is reviewed in the article.
Authors: Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik Journal: Chest Date: 2012-02 Impact factor: 9.410
Authors: Maria do Carmo Borges de Souza; Marcelo Marinho de Souza; Roberto de Azevedo Antunes; Maria Augusta Tamm; Joyce Barreto da Silva; Ana Cristina Allemand Mancebo Journal: JBRA Assist Reprod Date: 2019-01-31
Authors: Stephanie K Dahl; Sara Cannon; Mira Aubuchon; Daniel B Williams; Jared C Robins; Michael A Thomas Journal: J Assist Reprod Genet Date: 2009-06-23 Impact factor: 3.412
Authors: Veljko Vlaisavljevic; Susanna Apter; Antonio Capalbo; Arianna D'Angelo; Luca Gianaroli; Georg Griesinger; Efstratios M Kolibianakis; George Lainas; Tonko Mardesic; Tatjana Motrenko; Sari Pelkonen; Daniela Romualdi; Nathalie Vermeulen; Kelly Tilleman Journal: Hum Reprod Open Date: 2021-07-03